Satudora Holdings (3544) Fundamentals 2026 — P/E 39.9x, Revenue Analysis | SniperIQ
Satudora Holdings (3544) is a JP-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥17.3B, trading at ¥1258.00 on the JPX. This SniperIQ fundamentals page covers Satudora Holdings's valuation (P/E 39.9x, P/B 1.7x), profitability (net margin 0.4%), revenue (¥100.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Satudora Holdings's market cap?
Satudora Holdings (3544) has a market capitalization of approximately ¥17.3B, trading at ¥1258.00 on the JPX. Market cap moves with the live share price.
What is Satudora Holdings's P/E ratio?
Satudora Holdings's trailing twelve-month P/E ratio is 39.9x, with a price-to-book (P/B) of 1.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Satudora Holdings?
Satudora Holdings runs a net profit margin of 0.4%, a gross margin of 26.0%, and an operating margin of 1.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Satudora Holdings generate?
Satudora Holdings reported revenue of ¥100.6B for fiscal year 2025, with net income of ¥434M and earnings per share (EPS) of 31.51. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Satudora Holdings pay a dividend?
Satudora Holdings offers a trailing dividend yield of about 1.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Satudora Holdings financially healthy?
Satudora Holdings carries a debt-to-equity ratio of 1.51x and a current ratio of 1.09x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Satudora Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Satudora Holdings (3544) the key facts are: market cap ¥17.3B, P/E 39.9x, revenue ¥100.6B, 52-week range 791-1328. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Satudora Holdings's full fundamentals live
Get Satudora Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.